Current Issue
Volumes and Issues
For Authors
Manuscript Guidelines
Review Process
Conflict of Interest
Copyright
About the Journal
Editorial Board
Aim and Scope
Policy and Ethical Guidelines
Promotion of the Journal
Print-Version Subscription
Publisher and Contact Information
Contact Information
Sign in
ORIGINAL ARTICLE
REPORTING OF PATIENT-REPORTED OUTCOMES IN RCTS FOCUSED ON TINNITUS: A META STUDY
1
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, United States
2
Department of Internal Medicine, University of Oklahoma, School of Community Medicine, United States
3
Department of Psychiatry and Behavioral Sciences, Oklahoma State University Center for Health Sciences, United States
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article;
Submission date: 2022-04-14
Final revision date: 2022-07-19
Acceptance date: 2022-07-22
Publication date: 2022-09-30
Corresponding author
Rigel Bacani
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, 1111 West 17th Street, 74107, Tulsa, United States
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, 1111 West 17th Street, 74107, Tulsa, United States
J Hear Sci 2022;12(3):33-40
KEYWORDS
TOPICS
ABSTRACT
Background:
The inclusion of patient-reported outcomes (PROs) in randomized controlled trials (RCTs) supplements outcomes of treatment efficacy with the patient’s perspectives. The aim of this study was to evaluate reporting completeness of PROs in RCTs pertaining to tinnitus, using the Consolidated Standards of Reporting Trials (Consort-PRO) adaptation.
Material and methods:
We performed a search of Medline, Embase, and Cochrane Central Register of Controlled Trials (Central) for published RCTs related to tinnitus with at least one PRO measure from 2006 to 2020. Two investigators screened RCTs for inclusion. Using the Consort-PRO adaptation in an independent, masked fashion, investigators then evaluated all included RCTs. Similarly, all RCTs were evaluated using the Cochrane Collaboration Risk of Bias 2.0 tool. To assess relationships between trial characteristics and completeness of reporting, bivariate regression analyses were used.
Results:
From 878 publications, 37 RCTs met inclusion criteria. The mean Consort-PRO completeness of reporting across RCTs was 51.2% (SD = 20.8). Evaluation of our secondary outcome – assessment of study characteristics – demonstrated significantly higher completeness of reporting when (1) the Consort guideline was mentioned within the RCT (p = 0.01); (2) trials had ‘some concerns’ for bias (p = 0.001); and (3) trials had ‘low’ risk of bias (p = 0.001).
Conclusions:
Our study found that there was subpar Consort-PRO adherence within tinnitus RCTs. Due to the variance in symptom severity in tinnitus and the importance of PROs to clinical practice, we recommend journals include instructions to authors to use the Consort-PRO guideline before they publish RCTs.
The inclusion of patient-reported outcomes (PROs) in randomized controlled trials (RCTs) supplements outcomes of treatment efficacy with the patient’s perspectives. The aim of this study was to evaluate reporting completeness of PROs in RCTs pertaining to tinnitus, using the Consolidated Standards of Reporting Trials (Consort-PRO) adaptation.
Material and methods:
We performed a search of Medline, Embase, and Cochrane Central Register of Controlled Trials (Central) for published RCTs related to tinnitus with at least one PRO measure from 2006 to 2020. Two investigators screened RCTs for inclusion. Using the Consort-PRO adaptation in an independent, masked fashion, investigators then evaluated all included RCTs. Similarly, all RCTs were evaluated using the Cochrane Collaboration Risk of Bias 2.0 tool. To assess relationships between trial characteristics and completeness of reporting, bivariate regression analyses were used.
Results:
From 878 publications, 37 RCTs met inclusion criteria. The mean Consort-PRO completeness of reporting across RCTs was 51.2% (SD = 20.8). Evaluation of our secondary outcome – assessment of study characteristics – demonstrated significantly higher completeness of reporting when (1) the Consort guideline was mentioned within the RCT (p = 0.01); (2) trials had ‘some concerns’ for bias (p = 0.001); and (3) trials had ‘low’ risk of bias (p = 0.001).
Conclusions:
Our study found that there was subpar Consort-PRO adherence within tinnitus RCTs. Due to the variance in symptom severity in tinnitus and the importance of PROs to clinical practice, we recommend journals include instructions to authors to use the Consort-PRO guideline before they publish RCTs.
REFERENCES (35)
1.
Møller AR. Epidemiology of tinnitus in adults. In: Møller AR, Langguth B, De Ridder D, Kleinjung T, editors, Textbook of Tinnitus. Springer, New York; 2011, 29–37.Goldstein E, Ho C-X, Hanna R, Elinger C, Yaremchuk KL, Seidman MD, Jesse MT. Cost of care for subjective tinnitus in relation to patient satisfaction. Otolaryngol Head Neck Surg, 2015; 152(3): 518–23.
2.
Maes IHL, Cima RFF, Vlaeyen JW, Vlaeyen JW, Antenius LJC, Joore MA. Tinnitus: a cost study. Ear Hear, 2013; 34(4): 508–14.
3.
Maes IHL, Cima RFF, Anteunis LJC, Scheijen DJWM, Baguley DM, El Refaie A, et al. Cost-effectiveness of specialized treatment based on cognitive behavioral therapy versus usual care for tinnitus. Otol Neurotol, 2014; 35(5): 787–95.
4.
Han BI, Lee HW, Kim TY, Lim JS, Shin KS. Tinnitus: characteristics, causes, mechanisms, and treatments. J Clin Neurol, 2009; 5(1): 11–19.
5.
Salviati M, Macrì F, Terlizzi S, Melcore C, Provenzano A, Capparelli E, et al. The Tinnitus Handicap Inventory as a screening test for psychiatric comorbidity in patients with tinnitus. Psychosomatics, 2013; 54(3): 248–56.
6.
Duracinsky M, Mosnier I, Bouccara D, Sterkers O, Chassany O, Working Group of the Société Française d’Oto-Rhino-Laryngologie (ORL). Literature review of questionnaires assessing vertigo and dizziness, and their impact on patients’ quality of life. Value Health, 2007; 10(4): 273–84.
7.
Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD, CONSORT PRO Group. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA, 2013; 309(8): 814–22.
8.
Bullinger M, Quitmann J. Quality of life as patient-reported outcomes: principles of assessment. Dialogues Clin Neurosci, 2014; 16(2): 137–45.
9.
Kwatra SG, Kang S. Embracing the CONSORT statement for randomized controlled trials in dermatology. Br J Dermatol, 2019; 180(6): 1277–8.
10.
Mercieca-Bebber R, Rouette J, Calvert M, King MT, McLeod L, Holch P, et al. Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension. Qual Life Res, 2017; 26(6): 1427–37.
11.
Murad MH, Wang Z. Guidelines for reporting meta-epidemiological methodology research. Evid Based Med, 2017; 22(4): 139–42.
12.
Lefebvre C Manheimer E Glanville. Chapter 6: Searching for studies. In: Higgins JGS, editor. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011.
13.
Hillman C, Wise A, Vassar M, Heigle B, Shepard S, Hartwell M, et al. Tinnitus (July 2021). Available at https://osf.io/v2uhc/ [Accessed 2021.07.21].
15.
Risk of bias tools: Current version of RoB 2. Available at https://sites.google.com/site/.... Accessed 2021 Jul 21.
16.
Risk of bias tools: RoB 2 for crossover trials. Available at https://sites.google.com/site/.... Accessed 2021 Jul 21.
17.
Risk of bias tools: RoB 2 for cluster-randomized trials. Available at https://sites.google.com/site/.... Accessed 2021 Jul 21.
18.
Bylicki O, Gan HK, Joly F, Maillet D, You B, Péron J. Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy. Ann Oncol, 2015; 26(1): 231–7.
19.
Efficace F, Feuerstein M, Fayers P, Cafaro V, Eastham J, Pusic A, et al. Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making. Eur Urol. 2014; 66(3): 416–27.
20.
Mercieca-Bebber RL, Perreca A, King M, Macann A, Whale K, Soldati S, et al. Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: a systematic review of completeness of reporting and impact on interpretation. Eur J Cancer, 2016; 56: 144–61.
21.
Efficace F, Fayers P, Pusic A, Cemal Y, Yanagawa J, Jacobs M, et al. Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: a pooled analysis of 557 trials. Cancer, 2015; 121(18): 3335–42.
22.
Deshpande P, Sudeepthi B, Rajan S, Nazir CPA. Patientreported outcomes: a new era in clinical research. Persp Clin Res, 2011; 2(4): 137.
23.
Mercieca-Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas, 2018; 9: 353–67.
24.
Anker SD, Agewall S, Borggrefe M, Calvert M, Caro JJ, Cowie MR, et al. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J, 2014; 35(30): 2001–9.
25.
Kikidis D, Vassou E, Schlee W, Iliadou E, Markatos N, Triantafyllou A, Langguth B. Methodological aspects of randomized controlled trials for tinnitus: a systematic review and how a decision support system could overcome barriers. J Clin Med Res, 2021; 10(8): 1737.
26.
Landgrebe M, Azevedo A, Baguley D, Bauer C, Cacace A, Coelho C, et al. Methodological aspects of clinical trials in tinnitus: a proposal for an international standard. J Psychosom Res, 2012; 73(2): 112–21.
27.
Powell J, Powell S, Robson A. A systematic review of patientreported outcome measures in paediatric otolaryngology. J Laryngol Otol, 2018; 132(1): 2–7.
28.
Smith H, Fackrell K, Kennedy V, Barry J, Partridge L, Hoare DJ. A scoping review to catalogue tinnitus problems in children. Int J Pediatr Otorhinolaryngol, 2019; 122: 141–51.
29.
Skarżyński PH, Rajchel JJ, Gos E, Dziendziel B, Kutyba J, Bieńkowska K, et al. A revised grading system for the Tinnitus Handicap Inventory based on a large clinical population. Int J Audiol, 2020; 59(1): 61–67.
30.
Gos E, Sagan A, Skarzynski PH, Skarzynski H. Improved measurement of tinnitus severity: study of the dimensionality and reliability of the Tinnitus Handicap Inventory. PLoS One, 2020; 15(8): e0237778.
31.
Basch E, Barbera L, Kerrigan CL, Velikova G. Implementation of patient-reported outcomes in routine medical care. Am Soc Clin Oncol Educ Book, 2018; 38: 122–34.
32.
Mooney K, Berry DL, Whisenant M, Sjoberg D. Improving cancer care through the patient experience: how to use patientreported outcomes in clinical practice. Am Soc Clin Oncol Educ Book, 2017; 37: 695–704.
33.
Stover AM, Tompkins Stricker C, Hammelef K, Henson S, Carr P, Jansen J, et al. Using stakeholder engagement to overcome barriers to implementing patient-reported outcomes (PROs) in cancer care delivery: approaches from 3 prospective studies. Med Care, 2019; 57: S92–S99.
34.
Hall DA, Láinez MJA, Newman CW, Ganz Sanchez T, Egler M, Tennigkeit F, et al. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA. BMC Health Serv Res, 2011; 11: 302.
35.
Horsley T, Galipeau J, Petkovic J, Zeiter J, Hamstra SJ, Cook DA. Reporting quality and risk of bias in randomised trials in health professions education. Med Educ, 2017; 51(1): 61–71.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
